Poruchynsky M S, Ling V
Division of Molecular and Structural Biology, Ontario Cancer Institute, Princess Margaret Hospital, Toronto, Canada.
Biochemistry. 1994 Apr 12;33(14):4163-74. doi: 10.1021/bi00180a009.
P-glycoprotein (P-gp) is thought to function as a drug efflux pump in multidrug resistant (MDR) cells. The functional form of P-gp in its native state is not known. Previous results from radiation target size analysis have suggested that P-gp occurs as dimers in MDR cell plasma membranes [Boscoboinik et al. (1990) Biochim. Biophys. Acta 1027, 225-228]. In this study, we used sucrose gradient velocity sedimentation to determine if P-gp oligomers could be retrieved from detergent extracts of hamster and human MDR cell lines. The proportion of P-gp recovered as higher order oligomers was dependent on the detergents used for solubilization of the cells. When a detergent such as CHAPS was used, 50% or more of the P-gp sedimented as higher order oligomers. In contrast, in the presence of SDS, only monomers were retrieved, but naturally occurring oligomers could be preserved if the cells were treated with a cross-linker prior to detergent solubilization. The oligomers and monomers were both able to bind the photoactive analog of ATP (8-azido[alpha-32P]ATP) or the drug [3H]azidopine in membrane preparations. P-gp is a phosphoprotein, and its phosphorylated state is thought to be important for function. When MDR cells were labeled with [32P]orthophosphate in vivo, we observed that the monomer and dimer were more highly phosphorylated than the larger oligomers, suggesting that these different forms of P-gp may be functionally distinct. The assembly of oligomers appears to occur in an early bisynthetic compartment, and asparagine-linked glycosylation is not required for their formation. Our findings indicate that oligomers of P-gp exist in MDR cells and raise the possibility that the dynamics of oligomer formation and dissociation may be important in the mechanism of action of P-gp.
P-糖蛋白(P-gp)被认为在多药耐药(MDR)细胞中作为药物外排泵发挥作用。其天然状态下P-gp的功能形式尚不清楚。先前辐射靶标大小分析的结果表明,P-gp以二聚体形式存在于MDR细胞质膜中[博斯科博伊尼克等人(1990年),《生物化学与生物物理学报》1027卷,225 - 228页]。在本研究中,我们使用蔗糖梯度速度沉降法来确定是否可以从仓鼠和人MDR细胞系的去污剂提取物中回收P-gp寡聚体。以高阶寡聚体形式回收的P-gp比例取决于用于溶解细胞的去污剂。当使用诸如CHAPS之类的去污剂时,50%或更多的P-gp以高阶寡聚体形式沉降。相比之下,在SDS存在的情况下,仅回收单体,但如果在去污剂溶解前用交联剂处理细胞,则可以保留天然存在的寡聚体。寡聚体和单体在膜制剂中均能够结合ATP的光活性类似物(8-叠氮基[α-32P]ATP)或药物[3H]叠氮平。P-gp是一种磷蛋白,其磷酸化状态被认为对功能很重要。当在体内用[32P]正磷酸盐标记MDR细胞时,我们观察到单体和二聚体的磷酸化程度高于较大的寡聚体,这表明这些不同形式的P-gp可能在功能上有所不同。寡聚体的组装似乎发生在早期双合成区室中,并且其形成不需要天冬酰胺连接的糖基化。我们的研究结果表明,P-gp寡聚体存在于MDR细胞中,并增加了寡聚体形成和解离的动力学可能在P-gp作用机制中起重要作用的可能性。